The Enterprise Value as of September 2024 (TTM) for Soligenix, Inc. (SNGX) is 2.65M

According to Soligenix, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.65M. This represents a change of 4.77% compared to the average of 54.42K of the last 4 quarters.

Soligenix, Inc. (SNGX) Historical Enterprise Value (quarterly & annually)

How has SNGX Enterprise Value performed in the past?

The mean historical Enterprise Value of Soligenix, Inc. over the last ten years is 10.55M. The current 2.65M Enterprise Value has changed 2.41% with respect to the historical average. Over the past ten years (40 quarters), SNGX's Enterprise Value was at its highest in in the June 2015 quarter at 62.62M. The Enterprise Value was at its lowest in in the June 2023 quarter at -4927589.58.

Soligenix, Inc. (SNGX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Soligenix, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Soligenix, Inc. (SNGX) Average Enterprise Value

How has SNGX Enterprise Value performed in the past?

The current Enterprise Value of Soligenix, Inc. (SNGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Soligenix, Inc. (SNGX) Enterprise Value vs. Peers

How is SNGX’s Enterprise Value compared to its peers?

Soligenix, Inc.’s Enterprise Value is less than Zura Bio Limited (74.94M), greater than Apexigen, Inc. (205.32K), greater than Phio Pharmaceuticals Corp. (-1547761.00), less than eFFECTOR Therapeutics, Inc. (3.83M), less than Immix Biopharma, Inc. (25.98M), less than Addex Therapeutics Ltd (10.66M), greater than Aceragen, Inc. (-8243034.00), less than ERYTECH Pharma S.A. (42.66M), greater than Avenue Therapeutics, Inc. (-1054328.00), greater than Palisade Bio, Inc. (-6088350.00), greater than ContraFect Corporation (-1135867.00), greater than Allarity Therapeutics, Inc. (-14658905.00), less than CNS Pharmaceuticals, Inc. (3.78M), less than Windtree Therapeutics, Inc. (4.03M), greater than Dermata Therapeutics, Inc. (-1986143.00), less than Ensysce Biosciences, Inc. (3.14M), less than Panbela Therapeutics, Inc. (5.93M), less than Baudax Bio, Inc. (15.86M),

Build a custom stock screener for Soligenix, Inc. (SNGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Soligenix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Soligenix, Inc. (SNGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Soligenix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.